Jubilant Pharmova Ltd
NSE:JUBLPHARMA
Wall Street
Price Targets
JUBLPHARMA Price Targets Summary
Jubilant Pharmova Ltd
According to Wall Street analysts, the average 1-year price target for
JUBLPHARMA
is 787.95 INR
with a low forecast of 374.71 INR and a high forecast of 1 232.7 INR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is JUBLPHARMA's stock price target?
Price Target
787.95
INR
According to Wall Street analysts, the average 1-year price target for
JUBLPHARMA
is 787.95 INR
with a low forecast of 374.71 INR and a high forecast of 1 232.7 INR.
What is Jubilant Pharmova Ltd's Revenue forecast?
Projected CAGR
11%
For the last 8 years the
compound annual growth rate for
Jubilant Pharmova Ltd's revenue is
1%.
The projected
CAGR
for the next 2 years is
11%.
What is Jubilant Pharmova Ltd's Operating Income forecast?
Projected CAGR
49%
For the last 8 years the
compound annual growth rate for
Jubilant Pharmova Ltd's operating income is
0%.
The projected
CAGR
for the next 2 years is
49%.
You don't have any saved screeners yet
